文献速递心力衰竭与心肌病

肺功能受损与心力衰竭发病风险:NHLBI汇总队列研究

Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study.
PubMed 文献 · Eur Heart J · 2022-01-01

AIMS: The aim is to evaluate associations of lung function impairment with risk of incident heart failure (HF). METHODS AND RESULTS: Data were pooled across eight US population-based cohorts that enrolled participants from 1987 to 2004.…

要点

  • 阻塞性和限制性肺功能均增加心衰发病风险,限制性模式关联更强。
  • 肺功能受损主要与HFpEF相关,与HFrEF无显著关联。
  • 限制性肺功能与HFpEF的关联强度与高血压、糖尿病和吸烟相似。

核心结论

  • 肺功能受损与心力衰竭发病风险增加相关,尤其是HFpEF,其独立于主要已知心血管危险因素且关联强度相似。

研究设计与样本

  • 使用肺量计定义阻塞性(FEV1/FVC<0.70)或限制性(FEV1/FVC≥0.70且FVC<80%)肺功能。
  • 心衰事件定义为因心衰住院或死亡,部分事件亚分类为HFrEF(EF<50%)或HFpEF(EF≥50%)。
  • 采用Fine-Gray比例亚分布风险模型,调整社会人口学因素、吸烟和心血管危险因素。

主要发现

  • 中位随访21.0年,共发生3344例心衰事件。
  • 2066例可分类心衰事件中,1030例为HFrEF,1036例为HFpEF。
  • 阻塞性肺功能与心衰发病相关(校正HR 1.17,95%CI 1.07-1.27)。
  • 限制性肺功能与心衰发病相关(校正HR 1.43,95%CI 1.27-1.62)。
  • 阻塞性和限制性通气缺陷均与HFpEF相关,但与HFrEF无显著关联。

关键数值与推荐

  • 阻塞性肺功能定义:FEV1/FVC<0.70。
  • 限制性肺功能定义:FEV1/FVC≥0.70且FVC<80%。
  • HFrEF定义:EF<50%;HFpEF定义:EF≥50%。
  • 限制性肺功能与HFpEF的关联强度与高血压、糖尿病和吸烟相似。

临床怎么用

  • 在心衰风险评估中应考虑肺功能受损,尤其是HFpEF风险。
  • 肺功能受损可作为HFpEF的额外危险标志,与高血压、糖尿病和吸烟同等重视。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim is to evaluate associations of lung function impairment with risk of incident heart failure (HF). METHODS AND RESULTS: Data were pooled across eight US population-based cohorts that enrolled participants from 1987 to 2004. Participants with self-reported baseline cardiovascular disease were excluded. Spirometry was used to define obstructive [forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC) <0.70] or restrictive (FEV1/FVC ≥0.70, FVC <80%) lung physiology. The incident HF was defined as hospitalization or death caused by HF. In a sub-set, HF events were sub-classified as HF with reduced ejection fraction (HFrEF; EF <50%) or preserved EF (HFpEF; EF ≥50%). The Fine-Gray proportional sub-distribution hazards models were adjusted for sociodemographic factors, smoking, and cardiovascular risk factors. In models of incident HF sub-types, HFrEF, HFpEF, and non-HF mortality were treated as competing risks. Among 31 677 adults, there were 3344 incident HF events over a median follow-up of 21.0 years. Of 2066 classifiable HF events, 1030 were classified as HFrEF and 1036 as HFpEF. Obstructive [adjusted hazard ratio (HR) 1.17, 95% confidence interval (CI) 1.07-1.27] and restrictive physiology (adjusted HR 1.43, 95% CI 1.27-1.62) were associated with incident HF. Obstructive and restrictive ventilatory defects were associated with HFpEF but not HFrEF. The magnitude of the association between restrictive physiology and HFpEF was similar to associations with hypertension, diabetes, and smoking. CONCLUSION: Lung function impairment was associated with increased risk of incident HF, and particularly incident HFpEF, independent of and to a similar extent as major known cardiovascular risk factors.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Eckhardt, Balte, Barr, et al. Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study. Eur Heart J. 2022. PMID: 35467708. doi:10.1093/eurheartj/ehac205

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。